Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy [NA]

View source ↗

Summary

A Ferris State University-sponsored clinical trial evaluating alpha-lipoic acid for the treatment and prevention of diabetic retinopathy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Ferris State University | Conditions: Moderate Non-proliferative Diabetic Retinopathy | NA | Status: TERMINATED